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Introduction
Assembly of the human immunodefi  ciency virus type 1 (HIV) 
is a highly regulated process that requires the spatially and tem-
porally coordinated recruitment of viral components, as well as 
key cellular proteins, to an appropriate membrane system. The 
site of HIV budding has been reported to vary for different host 
cells; in T cells and several nonhematopoietic cell lines, the 
  majority of virus particles assemble at the cell surface, but in 
macrophages these events occur almost entirely on intracel-
lular membranes (Gendelman et al., 1988; Orenstein et al., 1988; 
  Raposo et al., 2002; Pelchen-Matthews et al., 2003). Immuno-
labeling indicates that the intracellular sites of assembly in these 
cells are enriched in major histocompatibility complex class II 
(MHC-II) molecules, suggesting that they are MHC-II compart-
ments (MIICs) where MHC-II molecules acquire their peptide 
cargo (Raposo et al., 2002). In support of this view, the intracel-
lular virus-containing compartments (VCCs) also label for some 
markers of late endosomes, such as the tetraspanin CD63 
(Raposo et al., 2002; Pelchen-Matthews et al., 2003; Kramer 
et al., 2005). Several studies with T cells, or cell lines such as 
HeLa, COS, or HEK293, have also demonstrated a limited and/
or transient association of assembling HIV, or of Gag-based virus-
like particles, with CD63-containing late endosomes (Nydegger 
et al., 2003; Sherer et al., 2003; Grigorov et al., 2006; Perlman 
and Resh, 2006), suggesting an association between HIV assem-
bly and late endosomes in most cells (Resh, 2005). Nonetheless, 
many studies of T cells and nonhematopoietic cells producing 
HIV clearly show virus particles budding from the cell surface. 
This view is supported by several recent studies indicating that 
HIV Gag is targeted directly to the plasma membrane (Harila 
et al., 2006; Neil et al., 2006), probably through a specifi  c inter-
action of the matrix component of Gag with the plasma mem-
brane lipid phosphatidylinositol 4,5-bis-phosphate (PI[4,5]P2; 
Ono et al., 2004; Saad et al., 2006), and that HIV particles only 
reach endosomes as a result of endocytosis of virions formed at 
the cell surface. It has been suggested that this may also be the 
case for the intracellular accumulations of HIV seen in macro-
phages (Jouvenet et al., 2006).
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n macrophages, HIV-1 has been shown to bud into 
  intracellular structures that contain the late endosome 
marker CD63. We show that these organelles are not 
endosomes, but an internally sequestered plasma mem-
brane domain. Using immunoﬂ   uorescence microscopy 
and immunoelectron microscopy, we ﬁ  nd that HIV-1 buds 
into a compartment that contains the tetraspanins CD81, 
CD9, and CD53. On uninfected macrophages, these pro-
teins are seen at the cell surface and in intracellular vacu-
ole-like structures with a complex content of vesicles and 
interconnected membranes that lack endosome markers, 
including CD63. Signiﬁ  cantly, these structures are acces-
sible to small tracers (horseradish peroxidase or ruthe-
nium red) applied to cells at 4°C, indicating that they 
are connected to the cell surface. HIV assembles on, and 
  accumulates within, these intracellular compartments. 
  Furthermore, CD63 is recruited to the virus-containing 
  structures and incorporated into virions. These results indi-
cate that, in macrophages, HIV-1 exploits a previously 
undescribed intracellular plasma membrane domain to 
assemble infectious particles.
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Much of the evidence for HIV association with endosomes is 
based on immunolabeling for CD63. CD63 is a well-established 
marker for late endosomes, which are often multivesicular bodies 
(MVBs), where it is particularly enriched on the intralumenal 
vesicles (Escola et al., 1998; Kobayashi et al., 2000). Several 
other members of the tetraspanin superfamily have also been 
 reported to be associated with MVB. In particular, CD53, CD81, 
and CD82 have been found to localize to MVB in B cells and 
are enriched on exosomes, which are the secreted MVB intra-
lumenal vesicles derived from these cells (Escola et al., 1998; 
Fritzsching et al., 2002). Similarly, CD9 has been found on exo-
somes from dendritic cells (DCs; Thery et al., 1999). Like CD63, 
CD81 can be incorporated into the envelope of infectious HIV 
produced by human monocyte–derived macrophages (MDMs; 
Nguyen et al., 2003; Pelchen-Matthews et al., 2003). Indeed, 
tetraspanin microdomains containing CD81 and CD63 have 
been proposed as sites of HIV assembly and release (Booth 
et al., 2006; Nydegger et al., 2006).
To further characterize the HIV assembly compartment in 
human primary MDMs, particularly in regard to its tetraspanin 
content, we have studied the distribution of CD81 and the re-
lated tetraspanins, CD9 and CD53. We show that in uninfected 
MDMs, these molecules are located at the plasma membrane 
and in intracellular structures with a complex array of internal 
CD81/CD9-labeled membrane vesicles and networks. These 
structures can be reached by antibodies internalized from the 
cell surface, but are distinct from early endosomes and from 
the late endosomes and lysosomes identifi   ed by CD63 and 
LAMP-1. On HIV-infected MDMs, virus particles bud into 
this intracellular CD81/CD9/CD53-containing compartment. 
Signifi  cantly, the VCCs are linked to the cell surface by nar-
row membrane channels. Notably, HIV infection recruits CD63 
to the CD81/CD9/CD53-positive VCCs. Thus, it appears that 
the HIV assembly compartment in macrophages is not a con-
ventional late endosome, but an internally sequestered plasma 
membrane domain to which the late endosome marker CD63 is 
recruited during virus assembly in HIV-infected cells.
Results
In macrophages, HIV assembles 
in a compartment containing 
CD63, CD81, and CD9
Previous analyses of HIV-infected MDMs indicated that most 
virus particles assemble on intracellular structures that contain 
markers for late endosomes, particularly CD63 (Raposo et al., 
2002; Pelchen-Matthews et al., 2003). Indeed, CD63 and another 
tetraspanin, CD81, are incorporated into the envelope of MDM-
derived infectious HIV particles (Nguyen et al., 2003; Pelchen-
Matthews et al., 2003). To examine in more detail the distribution 
of viral antigens compared with these cellular tetraspanins in 
  infected macrophages, we immunolabeled whole cells or semi-
thin (0.5 μm thick) cryosections for virus parti cles and for CD63, 
CD81, or the related tetraspanin, CD9 (Fig. 1 and Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200609050/DC1). 
Immunofl  uorescence revealed the usual distribution for CD63 in 
MDMs (Fig. 1, top row; Astarie-Dequeker et al., 2002), with the 
tubulovesicular pattern being reminiscent of the tubular lyso-
somes described in mouse macrophages (Swanson et al., 1987; 
Heuser, 1989; Robinson et al., 1996). In contrast, the viral antigens, 
Figure 1.  Colocalization of HIV with CD63, CD81, or CD9. Primary human MDMs infected with HIV for 10 d were ﬁ  xed and stained with mouse mAbs 
against CD63 (A–E), CD81 (F–J), or CD9 (K–O) and rabbit anti-HIV p17, followed by secondary anti–mouse Alexa Fluor 594 and anti–rabbit Alexa Fluor 
488 antibodies, and analyzed by confocal microscopy. A–C, F–H, and K–M show projections of 11, 20, and 21 confocal sections, respectively, whereas 
the images in the two right-hand columns are 0.5-μm-thick confocal sections from the center (D, I, and N) or near the bottom of the cells (E, J, and O). CD63 
was found in an extensive network of tubules and vesicles, and also stained the focus of viral p17 (A–D). CD81 and CD9 strongly decorated the cell surface 
(F and K), but also intracellular puncta near the bottom of the cells (J and O). On medial sections (I and N), the CD81 and CD9 labeling overlapped with 
the HIV-containing compartment. The asterisk in H marks HIV staining in a syncytium nearby. Bars, 10 μm.HIV ASSEMBLY IN A CD81/CD9/CD53 COMPARTMENT • DENEKA ET AL. 331
identifi  ed with rabbit antibodies against the viral matrix protein 
p17 (Fig. 1 B and S1 B) or p24 (not depicted) had a much more 
restricted distribution and  appeared to be associated with a subset 
of the CD63-containing organelles. The distributions of CD81 
and CD9 differed from that of CD63; mAbs to both CD81 and 
CD9 strongly labeled the plasma membrane of infected MDMs 
(Fig. 1, F and K) and, in addition, stained several punctate intra-
cellular structures (Fig. 1, J and O). In particular, the VCCs were 
strongly labeled for CD81 and CD9 (Fig. 1, I and N, and Fig. S1). 
This suggests that CD81 and CD9 more closely identify the HIV-
containing subpopulation of CD63-labeled organelles. However, 
the distribution of CD81 and CD9 has not been looked at system-
atically in uninfected MDMs.
CD63, CD9, CD53, and CD81 
in uninfected MDMs
Although many tetraspanins are prominently expressed at the 
plasma membrane, several have been found to be associated 
with intracellular compartments, including late endosomes. In 
particular, CD9, CD53, CD81, and CD82 have been localized to 
the intralumenal vesicles of MVBs or found on exosomes from 
B cell or DC lines (Escola et al., 1998; Thery et al., 1999). We 
analyzed the distribution of these markers in uninfected MDMs 
by immunofl  uorescence microscopy. As in the HIV-infected 
MDMs, CD63 was found in a tubuloreticular network  extending 
throughout the cells (Fig. 2 A). CD9, CD53, and CD81 showed 
a distinct distribution. On single confocal sections, CD9 and 
CD53, for example, were seen at the plasma membrane and also 
in discrete intracellular puncta (Fig. 2, B and C). These puncta 
measured up to 2–3 μm in diameter, and were larger than the 
CD63-containing structures, which did not exceed 0.5 μm diam. 
Typically, cells contained 20–30 of the larger CD9/CD53/
CD81-labeled structures, often close to or extending to  2.5 μm 
from the base of the cell.
Fig. 2 D shows by double labeling immunofl  uorescence 
that the majority of CD63 in uninfected MDMs was present on 
LAMP-1–positive tubules and vesicles. As suggested by the 
  distributions described in the previous paragraph, there was no 
  detectable overlap of the CD63-labeled network with the punctate 
staining for CD81 (Fig. 2 E). Instead, CD9, CD81, and CD53 co-
localized extensively with each other, both at the cell surface and 
in the intracellular puncta, shown here by costaining of CD9 with 
CD53 or CD81 (Fig. 2, F and G, respectively). To rule out the pos-
sibility that these structures represent a subset of early endosomes, 
we   costained the cells with an early endosome marker, EEA1. 
CD63 and CD9 showed only limited overlap with EEA1 (Fig. 2, 
H and I). The degree of colabeling was quantifi  ed using Volocity. 
This confi  rmed a high degree of colocalization between CD63 and 
LAMP-1 (94%), or between CD9 and CD81 or CD53 (84 and 
85%, respectively). In contrast, there was minimal overlap   between 
CD63 and CD81 or EEA1 (26 and 15%, respectively), and 
  between CD9 and EEA1 ( 20%), indicating the presence of dis-
crete structures containing either CD63 or the other tetraspanins, 
which are all largely distinct from early endosomes.
The CD81/CD9/CD53 compartment 
is accessible to antibodies fed at 37°C
To investigate whether the CD81/CD9/CD53-containing com-
partment in MDMs is related to the endosome system and 
whether it can be accessed from the plasma membrane, we 
Figure 2. Distribution of tetraspanins in uninfected 
MDMs. MDMs were grown for 16 d, ﬁ  xed, and stained 
with mAbs against CD63 (A), CD9 (B), or CD53 (C) and 
anti–mouse Alexa Fluor 488. CD63 labeled a network of 
tubular structures, whereas CD9 and CD53 localized to 
the cell surface and discrete intracellular puncta. To iden-
tify these puncta, cells were double stained with mouse 
IgG1 mAbs to LAMP-1, CD81, CD53, or EEA1, detected 
with anti–mouse IgG1-Alexa Fluor 594 (red), and IgG2b 
mAbs to CD63 or CD9, detected with anti–mouse IgG2b-
Alexa Fluor 488 (green). CD63 staining overlapped with 
LAMP-1 (D), but there was almost no colocalization of 
CD63 with CD81 (E). CD9 labeling showed nearly com-
plete overlap with CD53 (F) or CD81 (G). Neither CD63 
(H) nor CD9 (I) colocalized with EEA1. The images show 
single confocal sections  1 μm from the bottom of the cell. 
For D–G and I, the insets show enlargements. Bars, 10 μm.JCB • VOLUME 177 • NUMBER 2 • 2007  332
  performed antibody-feeding experiments. Uninfected MDMs 
were incubated for 3 h at 37°C with mAbs to CD81, CD9, or 
CD53, and then fi  xed, permeabilized, and processed for immuno-
fl  uorescence labeling. The antibodies strongly stained the cell 
surface (Fig. S2, A and D, available at http://www.jcb.org/cgi/
content/full/jcb.200609050/DC1). In addition, some of the anti-
bodies were taken up into intracellular vesicles resembling the 
aforementioned puncta (Fig. S2), whereas an irrelevant control 
antibody did not enter the cells under these conditions (not 
  depicted). To test whether the internalized antibodies could ac-
cess the CD81/CD9/CD53-containing compartment, antibody-
feeding experiments were combined with steady-state staining 
for different tetraspanins. Fig. 3 shows that anti-CD81 or -CD53 
mAbs could reach the CD9-positive compartment (Fig. 3, A 
and B), and internalized anti-CD9 mAbs colocalized with CD53 
and CD81 (Fig. 3, C and D). Uptake of the antitetraspanin mAbs 
was temperature dependent, and labeling was restricted to the 
cell surface after incubation at 4°C (Fig. S2, B and E). This 
  indicates that the CD81/CD9/CD53-containing compartment 
can be reached by antibodies fed from the cell surface at 37°C, 
although the mechanism of uptake remains unknown.
Ultrastructure of the CD81/CD9/CD53 
compartment
To analyze the morphology of the MDM CD81/CD9/CD53-
containing compartment in more detail, ultrathin cryosections 
were labeled with anti-CD9 or -CD81 mAbs and protein A-
gold (PAG) and examined by EM. On sections labeled for CD9, 
abundant gold particles were found over cell surface microvilli 
and membrane ruffl  es. In addition, we occasionally observed 
labeling over three types of intracellular structures. The fi  rst 
type is large vacuole-like structures (1–1.5 μm diam) contain-
ing various internal membranes, ranging from 50 nm diam ves-
icles resembling the intralumenal vesicles of MVBs to larger 
membranes (Fig. 4 A and B). The second type is composed of 
extended membrane swirls, usually consisting of two closely 
apposed membranes separated by a narrow gap (Fig. 4 C and D). 
These are likely to be profi  les of larger membrane sheets in 
Figure 3.  Uptake of antibodies directed against tetraspanins. MDMs cul-
tured for 13 d were incubated for 3 h at 37°C in medium containing mAbs 
against CD81, CD53, or CD9 (fed). Cells were then ﬁ  xed, permeabilized, 
and stained with antibodies against a different tetraspanin (steady-state). 
Antibodies were detected with isotype-speciﬁ  c secondary antibodies (red, 
anti–mouse IgG1-Alexa Fluor 594, for CD81 and CD53; green, anti–
mouse IgG2b-Alexa Fluor 488, for CD9). CD9 colocalized with internal-
ized anti-CD81 (A) or anti-CD53 (B). Similarly, internalized anti-CD9 was 
found in intracellular structures positive for CD53 (C) or CD81 (D). The im-
ages are from single confocal sections  1 μm from the bottom of the cell, 
and selected areas are shown enlarged in the insets. Bars, 10 μm.
Figure 4.  EM analysis of the CD81- and CD9-containing compartment in 
uninfected MDMs. Ultrathin cryosections from uninfected MDMs (14 d after 
isolation in A, B, E, and G–I; 26 d after isolation in C, D, F, and J) were 
stained with mouse mAbs against CD9 (A–G), CD81 (H and I) or CD63 (J), 
followed by a rabbit anti–mouse IgG bridging antibody and PAG (A–I, 
15 nm; J, 10 nm). The black arrow in A marks some small (50 nm diam) 
vesicles reminiscent of the intralumenal vesicles of MVBs. Black arrow-
heads in B identify apposed membrane sheets, and the white arrowheads 
in D show a thick coating on some of these apposed membrane sheets. The 
white arrow marks a coated pit. Su, cell surface; N, nucleus. Bars: (A, C, 
and E–J) 200 nm; (B and D) 500 nm.HIV ASSEMBLY IN A CD81/CD9/CD53 COMPARTMENT • DENEKA ET AL. 333
the sections. Occasionally, such membranes were lined with 
an extended dense coat (Fig. 4 D), and some MVB-like struc-
tures had extensions of the apposed parallel membrane sheets 
(Fig. 4 B). The third type appeared like arrays of highly inter-
connected membranes (Fig. 4, E–G and I). These structures 
were not enclosed in a continuous limiting membrane, allow-
ing extensions of the cytoplasm into the membrane meshwork 
and giving it a spongelike appearance. The compartments 
identifi  ed by the anti-CD9 or -CD81 antibodies differed from 
the structures labeled for CD63. In keeping with the many 
small vesicles and tubulovesicular structures seen by immuno-
fluorescence, anti-CD63 antibodies labeled various small 
mem  brane vesicles and tubules, often close to the nucleus (Fig. 
4 J). This, again, indicates that CD63 and the tetraspanins 
CD81, CD9, and CD53 are located in distinct structures in un-
infected MDMs.
HIV assembles in the CD81/CD9/CD53 
compartment
Immunofl  uorescence staining of HIV-infected MDMs demon-
strated that the virus, which was detected with anti-p17, was 
localized to VCCs that costained with CD81, CD9 (Fig. 1 and 
Fig. S1), and CD53 (not depicted), indicating that HIV assem-
bles in the CD81/CD9/CD53 compartment. The VCCs appeared 
larger and more irregular than the CD81/CD9/CD53-contain-
ing puncta seen in uninfected MDMs, and were usually located 
higher in the cell (compare Fig. 1, D, I and N with E, J, and O), 
suggesting that HIV infection may expand the CD81/CD9/
CD53-containing structures or cause them to coalesce. In ad-
dition to staining of the VCCs, some tetraspanin labeling was 
also observed in virus-negative intracellular puncta in the cells 
and at the plasma membrane, indicating that viral components 
are directed to a subset of the CD81/CD9/CD53-containing 
membranes. Little, if any, labeling for p17 was seen at the 
cell surface.
EM immunolabeling of ultrathin cryosections of HIV-
infected MDMs revealed VCCs that resembled the intracel-
lular CD81- or CD9-labeled structures seen in uninfected cells. 
The sections in Fig. 5 were double-labeled with 5 nm PAG 
marking p17 and 15 nm PAG identifying CD9 or CD81. Virus 
particles labeled for p17 could be seen in a variety of struc-
tures ranging from 0.5 μm to several micrometers in diameter 
(Fig. 5, A and B), some of which also contained internal vesi-
cles and larger membranes that labeled strongly for CD9 (Fig. 
5 A) and resembled the multivesicular structures shown in 
Fig. 4 (A and B). The VCCs in Fig. 5 C also has patches of 
fl  at coat on its limiting membrane (compare with Pelchen-
Matthews et al., 2003) and a long, curved double-membrane 
sheet linking its two poles. Double labeling for virus and 
CD81 revealed similar structures. The VCC in Fig. 5 D contains 
some CD81-labeled small vesicles similar to MVB intra lumenal 
vesicles. Two small VCCs in Fig. 5 E appear to be connected 
to extended CD81-labeled parallel membrane tracks (the ex-
tent of these membranes is shown at lower magnification in 
Fig. S3 A, available at http://www.jcb.org/cgi/content/full/jcb
.200609050/DC1).
Figure 5.  CD9 and CD81 in VCCs in MDMs. Ultrathin 
cryosections from MDMs infected with HIV for 7 d were 
double labeled with mouse mAbs against CD9 (A–C) or 
CD81 (D and E) and 15 nm PAG, followed by rabbit anti-
p17 and 5 nm PAG. HIV virions are identiﬁ  ed by their 
characteristic size (120–140 nm diam) and morphology 
and by labeling with 5 nm PAG (some virions are marked 
V in A–E). CD9 and CD81 are found in the VCCs, occa-
sionally even in the viral envelopes, as well as over inter-
nal membranes of various sizes and including small (50 nm 
diam) vesicles (A and D, black arrows). Note the thick 
protein coat on the apposed membrane sheets in C (white 
arrowheads) and the extended areas of closely apposed 
membrane sheets in E (black arrowheads). Bars, 200 nm.JCB • VOLUME 177 • NUMBER 2 • 2007  334
The virus assembly compartment 
in Epon-embedded MDMs
Transmission EM of plastic-embedded, HIV-infected MDMs, 
where the ultrastructure of virus particles is much clearer, 
also indicated that HIV accumulated in intracellular structures 
that morphologically resembled the CD9- or CD81-labeled 
  organelles observed on cryosections. Virions were found in 
VCCs in the juxtanuclear area (Fig. 6 A). Often, several such 
VCCs were located in close proximity, separated by thin mem-
brane bridges, or with fi  ngerlike membrane projections pro-
truding into their interior (Fig. 6 B). Occasionally, coated pits 
could be seen on the limiting membranes. Other VCCs were 
associated with extended swirls of closely apposed membrane 
sheets (Fig. 6, C and D). Fig. 6 E shows part of a large VCC in 
the vicinity of an unusual structure consisting of highly inter-
connected membranes. Although this had an overall rounded 
appearance, it lacked a continuous limiting membrane, so that 
tracks of cytoplasm permeated deep into the membrane mesh-
work. This structure resembles the spongelike structures labeled 
for CD9 or CD81 (compare Fig. 4, E–G and I, respectively). 
In Fig. 6 E, a spongelike structure was located near a VCC, 
and many other VCCs were found close to, or appeared to 
arise from, such structures. For example, Fig. 6 F shows an 
extended area of interconnected membrane meshwork with 
peri pheral  pockets of virus particles; indeed, one virion can 
be seen in the center of the spongelike region (Fig. 6 F, V). 
Smaller interconnected membranes, which might be resi-
dues of spongelike elements, were also apparent in Fig. 6 G 
(asterisks). The presence of budding fi  gures and immature virus 
particles within these structures, and association with the inter-
connected sponge membranes (Fig. 6 G, arrowheads), indicates 
that HIV particles are assembled on these membranes. Overall, 
spongelike structures of various sizes were found associated 
with  30% of the VCCs. Although these structures were rela-
tively rare in the MDMs, their frequent association with HIV 
assembly sites indicates that they are involved in virus bud-
ding, perhaps providing a source of membranes to form the 
viral envelopes.
Analysis of serial sections of HIV-infected macrophages 
by EM (Fig. 7) further demonstrated the complexity of the virus 
assembly compartments. Although the end sections show rela-
tively simple VCCs (Fig. 7, K or L), the central sections (Fig. 7, 
D–I) reveal interconnected chambers and a large spongelike re-
gion surrounded by assembled viruses. Budding profi  les and 
Figure 6. Morphology of VCCs in HIV-infected 
MDMs. MDMs infected with HIV for 14 d (or 13 d for 
the cell shown in G) were ﬁ   xed and embedded in 
Epon for transmission EM. (A and B) Virus particles, 
identiﬁ   ed by their characteristic morphology, were 
seen in VCCs in the juxtanuclear region. Note the 
coated pits associated with the VCCs (white arrows in B). 
N, nucleus; L, lipid droplets. (C and D) VCCs asso-
ciated with extended swirls of closely apposed mem-
brane sheets (black arrowheads; V marks some of the 
virions in D). (E) A spongelike meshwork of intercon-
nected membranes (asterisk) near a large, swollen 
VCC. V, virus particle; Go, Golgi complex. (F and G) 
Spongelike interconnected membranes (F) or remnants 
of such structures (G, asterisks) were frequently seen 
associated with VCCs. (V marks a virion deep in a 
membrane-sponge in F, white arrowheads show 
coated apposed membranes, black arrows indicate 
budding virus particles in G). Su, cell surface. Bars: 
(A–C and E–G) 500 nm; (D), 200 nm.HIV ASSEMBLY IN A CD81/CD9/CD53 COMPARTMENT • DENEKA ET AL. 335
immature virus particles are apparent on several of the panels 
(Fig. 7, A, B, and G–K), indicating that HIV assembly occurs 
directly into this compartment. Some buds can even be seen to 
arise from the spongelike structure in the core of the VCCs (Fig. 
7 G). Signifi  cantly, although budding profi  les and virus particles 
could be seen in intracellular VCCs, no such structures were 
found at the cell surface (Fig. S4 A, available at http://www.jcb
.org/cgi/content/full/jcb.200609050/DC1). The serial section 
images in Fig. S4 show that even apparently dispersed VCCs 
are connected in some sections and associated with condensed 
spongelike structures. Some VCCs were connected to mem-
brane tracks or parallel membrane sheets (Fig. 6, C and D; and 
Fig. S3), suggesting that they may be linked by elongated tubu-
lar extensions or via the closely apposed membrane sheets, and 
raised the possibility that some apparently intracellular VCCs 
may be connected to the cell surface.
The VCCs are connected 
to the cell surface
To test whether the VCCs are accessible from the cell surface, 
HIV-infected or uninfected MDMs fed for 3 h with anti-CD81 
mAb, were cooled on ice and incubated for 1 h at 4°C in me-
dium containing 10 mg/ml HRP. Subsequently, the cells were 
fi   xed and prepared for cryosectioning. Immunofl  uorescence 
staining of semithin cryosections for HIV p17, CD81, and HRP 
indicated that the HRP had reached the CD81-labeled VCC, 
even though this structure appeared to be located deep within 
the cell (Fig. 8, A–E). Similarly, HRP could access many of the 
puncta into which CD81 antibodies were internalized on un-
infected cells (Fig. 8, F–J). Surface connections were also appar-
ent on HIV-infected macrophages fi  xed in the presence of the 
electron-dense, cell-impermeant dye ruthenium red (RR). HIV 
particles located in apparently intracellular VCCs and clearly 
identifi  ed by their characteristic morphology were coated with 
a layer of RR (Fig. 8 K). The dye appeared to gain access to the 
virus particles through the narrow gaps between closely ap-
posed membrane sheets, which could be traced from the cell 
surface to the deep VCCs (Fig. 8 L). Indeed, most of the VCCs 
in this image appear to be connected by narrow membrane 
tracks. The surface connections were particularly clear on se-
rial sections. The images in Fig. 8 (N–Q) show a narrow RR-
stained channel linking three interconnected VCCs to the cell 
surface. Although the VCCs were accessible to a tracer from 
the extracellular medium, the connecting membrane tracks 
were always very narrow. The space between the membrane 
sheets appears to be  15–20 nm on Epon sections, or 25–30 nm 
on cryosections, which is far too narrow for virions ( 140 nm 
diam) to pass through.
Figure 7.  Serial sections of VCC in HIV-
  infected MDM. MDMs infected with HIV for 13 d 
were ﬁ  xed, embedded in Epon, and serial ultra-
thin sections were cut through the virus-containing 
areas. The images shown were prepared from 
a series of 29 consecutive 70–80-nm sections 
(the section number relative to the ﬁ  rst section 
in the set is indicated in the top right corner 
of each panel). Note the spongelike intercon-
nected membranes, particularly in the more 
central sections of the set (F and H, asterisks). 
V marks selected virus particles embedded 
within the spongelike structures (in C, E, F, 
and H), white arrowheads indicate coated 
  apposed membranes in I, the white arrow in 
K marks a coated pit, and the black arrows 
(in A, B, G–J, and K) identify budding viruses 
or   immature HIV particles. Bar, 1 μm.JCB • VOLUME 177 • NUMBER 2 • 2007  336
HIV infection changes the CD81/CD9/
CD53 compartment in MDMs
Although it appears that HIV targets the CD81/CD9/CD53 
compartment, there are some differences between the CD81/
CD9/CD53-labeled structures observed in uninfected MDMs 
and the VCCs in HIV-infected macrophages. The CD81/CD9/
CD53-labeled structures were usually observed near the bottom 
of the cell (Fig. 2), whereas the VCCs were often found in 
higher, more medial confocal sections (Fig. 1). Furthermore, 
VCCs often appeared enlarged or expanded compared with the 
CD81/CD9/CD53-labeled structures in uninfected MDMs.
The most striking difference, however, was in the distri-
bution of CD63 relative to the CD81/CD9/CD53 compartment. 
On uninfected MDMs, there was no overlap between the late 
endosome marker CD63 and CD81, CD9, or CD53 (Fig. 2 E), 
whereas infected MDMs showed colabeling of viral p17 and 
CD63 (Fig. 1 and S1; Raposo et al., 2002; Pelchen-Matthews 
et al., 2003). This suggests that CD63 must be recruited to the 
VCCs in HIV-infected MDMs. To investigate whether CD63 
traffi  cking over the cell surface has access to the VCCs, we in-
cubated HIV-infected macrophages with an anti-CD63 mAb for 
3 h at 37°C. Cells were then washed, fi  xed, permeabilized, and 
Figure 8.  The intracellular VCCs are accessible from the cell 
surface. (A–J) The ﬂ  uid tracer HRP has access to the VCCs. 
MDMs infected with HIV for 8 d (A–E) or uninfected MDMs 
cultured for 13 d and incubated with anti-CD81 for 3 h at 
37°C (F-J) were cooled on ice and incubated for 1 h at 4°C 
with 10 mg/ml HRP. Cells were ﬁ  xed and processed for cryo-
sectioning. Semithin (0.5 μm thick) sections were triple-stained 
with anti-p17 mouse IgG2a (A and F, visualized with anti–
IgG2a-Alexa Fluor 488, green), anti-CD81 mouse IgG1 (B, 
anti-IgG1-Alexa Fluor 594, red, or in G, second antibody 
only) and rabbit anti-HRP (C and H, anti–rabbit-Alexa Fluor 
697, blue). Merged immunoﬂ  uorescence (D and I) and phase-
contrast (E and J) images of the sections. HRP reached the 
CD81-labeled virus-containing structures (D) or the structure 
containing the fed anti-CD81 (I). (K–Q) MDMs infected with 
HIV for 13 d were ﬁ  xed in the presence of RR and embedded 
in Epon. RR marks surface-accessible membranes with a ﬂ  oc-
culated, electron-dense deposit. In K, virus particles inside 
VCCs were coated with RR. L shows extended closely ap-
posed membrane sheets (black arrowheads) near the cell sur-
face (Su) or deep in the cell. The asterisks mark RR-stained 
membranes cut parallel to the section; the area under the 
white asterisk links these structures to the cell surface (see the 
enlargement in M). #, interconnected spongelike membranes 
deep in the cell. V, virus particles; Li, lipid droplets. (N–Q) 
Sections 28, 27, 26, and 24, respectively, of a set of 41 se-
rial sections. The black arrowheads in (N and O) mark a thin 
channel of RR-stained membranes from the cell surface (Su) 
into VCC 1. In P, VCCs 1 and 2 are coalescing (the edge of 
the compartment membrane is cut grazingly at the white ar-
rowhead). In Q, VCCs 1 and 2 are fused, and are connected 
to VCC 3 through a narrow gap (arrow). Bars: (D and I) 10 μm; 
(K) 200 nm; (L and Q) 500 nm.HIV ASSEMBLY IN A CD81/CD9/CD53 COMPARTMENT • DENEKA ET AL. 337
stained with antibodies against CD53 and p17. CD53 weakly 
stained the cell surface, and also labeled several discrete intra-
cellular puncta (Fig. 9 A). In addition, it decorated the VCCs 
identifi  ed by anti-p17 labeling (Fig. 9, B and D). The internal-
ized anti-CD63 mAb was not seen in the tubulovesicular struc-
tures that were so prominent in the steady-state staining studies 
(compare the staining pattern of fed anti-CD63 [Fig. 9] to steady 
state [Figs. 1 and 2]). Instead, internalized anti-CD63 was seen 
in dispersed round vesicles and also localized strongly to the 
VCCs (Fig. 9 C). When we performed anti-CD63 feeding ex-
periments on uninfected MDMs, the internalized anti-CD63 
again did not reach the tubulovesicular network within the 3-h 
time course examined, but was seen in small vesicles dispersed 
throughout the cytoplasm (Fig. S5 A, available at http://www
.jcb.org/cgi/content/full/jcb.200609050/DC1). In a small pro-
portion of these vesicles, the internalized CD63 colocalized 
with EEA1 (Fig. S5 B) or with CD53 (Fig. S5 C), suggesting 
that at least a proportion of the cellular CD63 pool cycles over 
the plasma membrane and passes through early endosomes and 
the CD81/CD9/CD53 compartment. In HIV-infected cells, this 
cycling CD63 population may become trapped in the VCCs, 
perhaps by being incorporated into budding virions (Pelchen-
Matthews et al., 2003).
Localization of HIV Env to the CD81/CD9/
CD53 compartment in MDMs
The distribution of HIV in infected MDMs has been largely de-
termined using antibodies against the Gag protein. However, 
the production of infectious particles also requires the viral en-
velope protein (Env). We studied Env using the human anti-Env 
mAb 2G12, which binds an epitope covering several N-linked 
glycosylation sites (Scanlan et al., 2002) and appears to recog-
nize post-ER forms of the viral glycoprotein (Byland et al., 
2007). To avoid binding of the mAb to macrophage Fc recep-
tors, F(ab′)2 fragments of 2G12 were generated for immuno-
fl  uorescence staining. Env was observed in the intracellular VCCs, 
where it colocalized with the capsid protein p24 (Fig. 10 A). 
Env staining in HIV-infected MDMs also overlapped closely 
with CD81 (Fig. 10 B). To determine whether Env itself can 
  target the CD81 compartment, Env was expressed in uninfected 
MDMs by nucleofection. Env was observed almost exclusively 
in the intracellular CD81-containing compartment (Fig. 10 C) 
and did not colocalize with the tubulovesicular late endosomes 
identifi  ed by CD63 (Fig. 10 D). As in uninfected MDMs (Fig. 
3 A), CD63 and CD81 did not colocalize in the Env-transfected 
MDMs. Thus, the viral Env glycoprotein appears to be targeted 
to the CD81/CD9/CD53 compartment.
Discussion
In this study, we have further characterized the compartment 
where HIV assembles in MDMs. Although in macrophages 
HIV particles accumulate in structures with the appearance of 
vacuoles that contain the late endosome marker CD63, our 
  results indicate that these compartments are not endosomes. 
  Instead, we have shown that the virus assembly sites are marked 
by the tetraspanins CD81, CD9, and CD53. Immunofl  uores-
cence staining of uninfected MDMs indicated that CD81, CD9, 
and CD53 are present at the plasma membrane and in a population 
of intracellular puncta that are distinct from EEA1-containing early 
endosomes or the tubulovesicular late endosomes/lysosomes 
marked by CD63 and LAMP-1. EM analysis revealed a complex 
morphology for these structures, with multivesicular-like com-
ponents, closely apposed extended membrane sheets, extensive 
interconnected spongelike membranes, and lipid deposits, which 
are structures that are clearly distinct from endocytic organelles. 
Notably, both CD9 and CD81 were located on the internal 
membranes of these structures, suggesting that, in MDMs at 
least, multivesicular organelles are heterogeneous; CD9 and 
CD81 do not mark endosomes and, in uninfected cells, CD63 
does not localize to the multivesicular CD81/CD9/CD53 com-
partment. In addition, we now report that the CD81/CD9/CD53 
Figure 9.  Anti-CD63 antibodies can access 
the VCCs. MDMs infected with HIV for 10 d 
were incubated for 3 h at 37°C in medium 
with anti-CD63 (mouse IgG2b). Cells were 
ﬁ   xed, permeabilized, and labeled with anti-
bodies against CD53 (mouse IgG1) and p17 
(rabbit polyclonal), followed by anti–mouse 
IgG1-Alexa Fluor 594 and anti–rabbit Alexa 
Fluor 488. Internalized anti-CD63 was detected 
with biotin-conjugated anti-IgG2b, followed by 
Cy5-conjugated streptavidin. (A–C) show the 
distribution of CD53 (red), viral p17 (green), 
and internalized anti-CD63 (blue), respectively, 
whereas D is a merged image. Selected areas 
are enlarged in (A’–D’). The internalized anti-
CD63 accumulated in the VCCs identiﬁ  ed by 
the presence of p17. These VCCs also co-
stained for CD53. The images show a projec-
tion of 11 confocal sections (0.5 μm thick). 
Bars: (D) 10 μm; (D’) 2.5 μm.JCB • VOLUME 177 • NUMBER 2 • 2007  338
compartment is linked to the cell surface, both in uninfected and 
HIV-infected cells, and so may be considered an internally se-
questered plasma membrane domain.
In MDMs infected with R5-tropic HIV, mature and imma-
ture virus particles and buds were seen in intracellular VCCs, 
as previously described (Gartner et al., 1986; Gendelman et al., 
1988; Orenstein et al., 1988; Sharova et al., 2005; Ryzhova et al., 
2006). In observations of a large number of cells on many 
  sections, we saw HIV budding profi  les at the limiting mem-
brane of VCCs and on the spongelike membranes and immature 
virions in the interior (Fig. 6 G and Fig. 7), but not at the cell 
surface proper. This suggests that the vast majority of HIV par-
ticles are formed directly at this site, rather than reaching the in-
tracellular location after endocytosis from the cell surface. 
Indeed, in infected MDMs, there were very few HIV particles at 
the cell surface available for endocytosis (Fig. S3 A), and vi-
rions were never seen in coated pits or in EEA1-positive early 
endosomes, as might be expected if virus accessed the VCCs 
by internalization from the cell surface. The HIV assembly 
compartment appeared to be derived from a subset of the struc-
tures marked by CD81, CD9, and CD53 because (a) immuno-
fl  uorescence labeling revealed a close overlap of the intracellular 
virus with these markers, (b) immuno-EM of cryosections 
showed virus particles associated with structures resembling the 
CD9- and CD81-containing internal membranes in uninfected 
MDMs, and (c) an EM analysis of Epon sections of infected 
MDMs revealed VCCs associated with interconnected sponge-
like membranes or extended parallel membrane sheets. Although 
some of the spongelike membranes on Epon sections resemble 
the paracrystalline ER described in cells overexpressing cer-
tain ER proteins (Yamamoto et al., 1996), we did not observe 
costaining between CD53 or CD81 and the ER marker calnexin   
(unpublished data).
HIV not only exploits the CD81/CD9/CD53 compartment 
for assembly, it also changes the compartment. Thus, virus in-
fection expands and/or causes the coalescence of the CD81/
CD9/CD53 structures, and it alters their distribution in infected 
cells. Most signifi  cantly, the VCCs also label for CD63, which 
is in agreement with previous studies (Raposo et al., 2002; 
Pelchen-Matthews et al., 2003; Ryzhova et al., 2006). However, 
our present studies indicate that CD63 only reaches the CD81/
CD9/CD53 compartment after infection by HIV. Antibody-
feeding experiments suggest that a pool of CD63 cycles over the 
cell surface and through CD81/CD9/CD53-labeled structures and 
that, in infected MDMs, this cycling CD63 can become trapped 
in the virus-containing CD81/CD9/CD53 compartment, perhaps 
through incorporation into HIV particles (Pelchen-Matthews 
et al., 2003).
Macrophages are unusual in that virus assembly occurs 
almost exclusively in intracellular VCCs. Nonetheless, experi-
ments in which MDMs were exposed to the fl  uid tracer HRP at 
4°C or fi  xed in the presence of the membrane-impermeant dye 
RR indicated that the VCCs are part of an unusual network of 
surface-connected intracellular structures. As all of the mem-
branes accessed by RR must be connected to the cell surface, 
they should strictly be classifi  ed as plasma membrane. Indeed, 
the intracellular, CD9-labeled membranes contain the plasma 
membrane lipid PI(4,5)P2, as demonstrated in preliminary ex-
periments with the phospholipase Cδ1 PH domain linked to 
GFP (unpublished data). Thus, in MDMs, as in other cells, HIV 
components appear to be targeted to the PI(4,5)P2-containing 
plasma membrane, but this domain, though linked to the cell 
surface, is sequestered within the cell. These observations are 
consistent with recently published data indicating that HIV as-
sembly does not occur on endosomes, but that the viral Gag 
protein is directly targeted to the plasma membrane (Jouvenet 
et al., 2006; Neil et al., 2006). To date, we have only seen the 
CD9- or CD81-labeled intracellular structures in MDMs or in 
some LPS-matured monocyte-derived DCs, but the compart-
ment is rare and diffi  cult to fi  nd, even in these cells. Thus, we 
cannot be sure whether similar structures exist in other cells, 
such as T cells or HeLa, which express the tetraspanins CD9 
and CD81 at lower levels. The surface-connected structures in 
macrophages may be related to the surface-connected patocyto-
sis compartment that is involved in the uptake and sequestration 
of aggregated cholesterol (Kruth, 2002).
How the viral components are targeted to the intracellular 
CD81/CD9/CD53-containing membranes is unclear. Virus as-
sembly may be stabilized at this compartment by the tetraspan-
ins, as it has been suggested that HIV assembly may be gated 
Figure 10.  Immunolocalization of the HIV envelope glycoprotein in 
MDMs. (A) MDMs infected with HIV for 10 d were ﬁ  xed, permeabilized, 
and stained with mouse mAbs against the HIV capsid protein p24 and 
F(ab’)2 fragments of the human anti-Env mAb 2G12, followed by anti–
mouse Alexa Fluor 594 (red) and anti–human FITC (green), respectively. 
(B) Alternatively, the cells were stained with anti-CD81 and -Env F(ab’)2. 
Env colocalized with assembling virus particles (p24), as well as with 
CD81. (C and D) Uninfected MDMs were nucleofected with pSVIII HxB2 
Env and the distribution of Env was analyzed 48 h after nucleofection, 
and after treatment with sodium butyrate to boost expression. Fixed 
and permeabilized cells were double labeled with anti-Env F(ab’)2 frag-
ments and antibodies against CD81 (C) or CD63 (D) and secondary anti-
bodies as in A. The images show single confocal sections (0.5 μm thick). 
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through tetraspanin-enriched microdomains (Nydegger et al., 
2006). It seems unlikely, however, that virus targeting to tet-
raspanin domains alone accounts for targeting to the VCCs be-
cause high levels of CD9 or CD81 are also found at the cell 
surface in MDMs, whereas the bulk of CD63 is in distinct late 
endosomes/lysosomes. Indeed, even within the CD81/CD9/
CD53 compartment, most of the tetraspanins appear to be se-
questered on the internal membranes. When the HIV Env pro-
tein was expressed alone in MDMs after transfection, it localized 
to intracellular vesicles that costained with CD81, but did not 
relocate CD63 to these structures, suggesting that other viral 
proteins are required for CD63 accumulation in the virus as-
sembly compartment.
Assembly in the CD81/CD9/CD53 compartment appears 
to offer several advantages for HIV. The compartment contains 
large amounts of membrane that can be used by the virus to 
form its envelopes. The assembled virus particles may then be 
stored in an infectious form until they are released (Sharova et al., 
2005). By EM, the channels that connect the virus-containing 
structures to the cell surface are very narrow (<20 nm on 
Epon sections), suggesting that although RR (Mr = 786) or 
HRP (40 kD) can pass through these gaps, the diffusion of larger 
antibody molecules, which are  10 nm long, may be impeded, 
and virus particles with diameters of 120–140 nm are retained 
in the cells. Generally, the spacing between the membrane 
sheets appeared very regular, even over extended distances (Fig. 
8 L and Fig. S3), suggesting that proteins lining the mem-
brane—perhaps together with the tetraspanins—support these 
structures. In some regions, we observed fl  at coats and cytoskel-
etal meshworks, presumably actin, associated with the mem-
brane tracks; these structures may further support membranes in 
the closely apposed confi  guration and perhaps regulate access. 
Indeed, treatment with cytochalasin D has been reported to dis-
rupt the VCCs in MDMs (Jouvenet et al., 2006). Because the 
VCCs are connected to the cell surface, virions would be in 
contact with the extracellular, most likely neutral, pH and not 
the harsh acidic/degradative environment of endosomes, and 
any stimuli that would open the connecting membrane channels 
would lead to the rapid release of virus particles, together with 
CD81/CD9-containing exosomes and other membrane struc-
tures present in the VCCs.
The possibility that HIV may be released from the CD81/
CD9/CD53 structures in a regulated manner is also suggested 
by analogy to the interaction of HIV with DCs, where compart-
ments marked by CD81 may play a role during antigen presen-
tation. CD81 has been shown to redistribute to the immunological 
synapse between T cells and either B cells or DCs, in an anti-
gen-dependent manner (Mittelbrunn et al., 2002). DCs, at least 
in tissue culture, are able to capture extracellular virus particles 
and later release them onto T cells for infection in trans (Kwon 
et al., 2002; McDonald et al., 2003; Garcia et al., 2005). The 
compartments into which HIV is internalized in DCs resemble 
the VCCs of MDMs in their size and complexity, internal vesi-
cles and membranes that label for CD81 or CD9, clathrin-coated 
pits, and extended areas of thickened fl  at coats. Notably, the DC 
virus-containing structures also lack markers for early endo-
somes or late endosomes and lysosomes and stain only weakly 
for CD63 (Garcia et al., 2005). In DCs, HIV can access the 
compartment by uptake from the cell surface, whereas in 
MDMs, virus assembles directly into the CD81/CD9/CD53 
compartment. The similarities between the viral compartments 
of DCs and MDMs suggest that the macrophage compartment 
may also be involved in virus transfer to target cells. Such pro-
cesses are likely to involve complex membrane rearrangements. 
In this respect, the narrow membrane channels and surface con-
nections from the MDM VCCs show some resemblance to the 
tubules induced during stimulation of murine DCs (Boes et al., 
2002; Chow et al., 2002).
MDMs are primary cells, but, as they have undergone 
differentiation in culture, we cannot be sure that the structures 
we describe in this study are present in macrophages in vivo, 
though intracellular assembly of virus was observed with both 
HIV types 1 and 2 and in brain macrophages of an individual 
with AIDS encephalopathy (Orenstein et al., 1988). Macro-
phages are widely distributed in all tissues and organs and are 
believed to be an important vehicle for spreading HIV infec-
tion to CD4
+ T cells (Herbein et al., 2002), perhaps because 
they sequester virus in intracellular compartments. Indeed, the 
HIV sequestered in MDMs can remain infectious for many 
days (Sharova et al., 2005). By analogy with studies on DCs, 
macrophages may likewise release HIV from the CD81/CD9/
CD53-containing VCCs when they encounter T cells (Sharova 
et al., 2005). For HIV, virological synapses have been described 
for conjugates between DCs and T cells or between infected 
and uninfected T cells (Piguet and Sattentau, 2004), and mac-
rophages have been shown to release HIV particles onto epi-
thelial cells (Bourinbaiar and Phillips, 1991) or peripheral 
blood lymphocytes (Carr et al., 1999) in a directed manner. 
The CD81/CD9/CD53 compartment may function in the for-
mation or activity of immunological synapses, and it is these 
properties that are exploited by HIV to facilitate cell–cell transfer 
through virological synapses. Moreover, the potential to hide 
virus intracellularly, beyond the reach of humoral immune re-
sponses, may have important implications for vaccine design 
and AIDS pathogenesis.
Materials and methods
Reagents and antibodies
Tissue culture media and supplements were obtained from Invitrogen, and 
tissue culture plastic was purchased from TPP. HRP type II and other chemi-
cals were obtained from Sigma-Aldrich, unless stated otherwise.
The mouse mAb against CD63 (1B5 and IgG2b) has been previ-
ously described (Fraile-Ramos et al., 2001); anti-CD81 (M38, IgG1) was 
provided by F. Berditchevski (University of Birmingham, Birmingham, UK); 
anti-CD53 (MEM-53 and IgG1) and anti-CD9 (MCA469GA and IgG2b) 
were purchased from Abcam and Serotec, respectively; anti–LAMP-1 
(H4A3 and IgG1) and anti-EEA1 (clone 14 and IgG1) were obtained from 
BD Biosciences. mAbs to HIV p17 (4C9, mouse IgG2a, and ARP342 were 
obtained from R.B. Ferns and R.S. Tedder, Middlesex Hospital Medical 
School, London UK), p24 (mAbs 38:96K and EF7, both mouse IgG1, 
ARP365, and 366, respectively, from B. Wahren, National Bacteriological 
Laboratory, Stockholm, Sweden), and Env (human mAb 2G12, EVA3064; 
obtained from H. Katinger, Institute of Applied Microbiology, Vienna, Aus-
tria) were obtained through the National Institute for Biological Standards 
and Control Centralised Facility for AIDS Reagents, which is supported by 
the EU Program EVA and the UK Medical Research Council. F(ab’)2 frag-
ments of 2G12 were generated using the ImmunoPure Preparation kit 
(Pierce). The rabbit antiserum UP595 against HIV p17 was provided by JCB • VOLUME 177 • NUMBER 2 • 2007  340
M. Malim (Guy’s, King’s and St Thomas’ School of Medicine, London, UK), 
rabbit anti-HRP was purchased from Jackson ImmunoResearch Laborato-
ries, rabbit anti–mouse bridging antibody was purchased from DakoCyto-
mation, and biotin-conjugated anti-IgG2b was purchased from Southern 
Biotechnology Associates. Alexa Fluor–labeled ﬂ  uorescent antibodies were 
obtained from Invitrogen, Cy5-streptavidin was purchased from Jackson 
ImmunoResearch Laboratories, and FITC goat anti–human was obtained 
from Pierce Chemical Co. PAG reagents were obtained from the EM Lab 
(Utrecht University, Utrecht, Netherlands).
Cells and viruses
Peripheral blood mononuclear cells (PBMCs) were prepared from buffy 
coats from healthy donors (National Blood Service, Essex, UK), and adher-
ent monocytes were isolated as previously described (Pelchen-Matthews 
et al., 2003). Monocytes were differentiated to MDMs in complete medium 
(RPMI 1640, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 10% hu-
man AB serum [PAA Laboratories] with 10 ng/ml of M-CSF [R&D Systems]) 
for 2 d, and then differentiated without M-CSF until required.
HIV-1BaL was obtained from R. Shattock (St. George’s Hospital, London, 
UK). A ﬁ  rst virus stock was prepared by infection of PHA-stimulated PBMC 
(grown in RPMI 1640 with penicillin, streptomycin, 10% FCS, and 20 U/ml 
Il-2 [R&D Systems] and treated for 3 d with 0.5 μg/ml PHA-P). PBMC-
grown HIV-1BaL was passaged once through MDMs to maintain tropism. 
Cell-free supernatants were harvested every 3 d, aliquoted, and stored in 
liquid nitrogen. Virus titers were determined on NP2-CD4-CCR5 cells as 
previously described (Pelchen-Matthews et al., 2003).
For experiments, MDMs were infected 6 d after isolation with HIV-
1BaL (2 FFU/cell) by spinoculation at 2.5 krpm for 2 h at RT, and cultured 
for various times as indicated. For infectivity assays, NP2-CD4-CCR5, were 
inoculated by spinoculation as above, and stained with X-Gal after 3 d 
(Pelchen-Matthews et al., 2003).
Nucleofection of HIV Env protein
MDMs were grown for 7 d, detached using trypsin/EDTA, and nucleo-
fected with pSVIII HxB2 Env (Helseth et al., 1990), using a Nucleofector 
with the macrophage nucleofection kit and program Y-10 (Amaxa).
Immunoﬂ  uorescence staining of whole-cell preparations
MDMs were ﬁ  xed by adding an equal volume of double-strength ﬁ  xative, 
6% PFA (TAAB Laboratories) to the culture medium for  30 min at RT. After 
washing, free-aldehyde groups were quenched with 50 mM NH4Cl, and 
the cells were permeabilized for 1 h in blocking buffer (0.1% saponin and 
0.5% BSA in PBS) containing 10 μg/ml puriﬁ  ed human IgG. Cells were 
stained with primary antibodies diluted in blocking buffer for 1 h, washed, 
and incubated for 1 h with appropriate combinations of ﬂ  uorescent secondary 
antibodies. Coverslips were mounted in Mowiol (Merck), and examined 
directly or stored at –20°C. Staining was analyzed with a microscope 
  (Optiphot-2; Nikon) equipped with an upright confocal laser scanner and 
a Plan Apochromat 60× oil-immersion lens (Nikon) and an upright confocal 
laser scanner (MRC 1024; Bio-Rad Laboratories). Images were acquired at RT 
using LaserSharp2000 (Bio-Rad Laboratories) and processed using Photo-
shop (Adobe) or ImageJ (National Institutes of Health). Volocity version 
3.6.1 was used to measure colocalization.
For some experiments, HIV-infected or uninfected MDMs were incu-
bated for 3 h at 37°C (or as a control at 4°C) with antibodies against CD9 
(4 μg/ml), CD81 (13.5 μg/ml), CD63 (1 μg/ml), or CD53 (20 μg/ml) in 
complete medium, washed, and processed for immunoﬂ  uorescence as in 
the previous paragraph.
EM methods
HIV-infected MDMs were ﬁ  xed for 4 h in 2% PFA/3% glutaraldehyde in 
0.1 M NaPi buffer, pH 7.4, postﬁ  xed for 1 h on ice in 1% OsO4/1.5% 
K3[Fe(CN)6], and treated with 1.5% tannic acid (Simionescu and Simio-
nescu, 1976). To test accessibility to the cell surface, some samples were 
ﬁ  xed for 4 h in the ﬁ  xative containing 5 mg/ml RR, postﬁ  xed 2 h in 1% 
OsO4/5 mg/ml RR, and stained for 1 h in 1% uranyl acetate. Samples 
were dehydrated in graded ethanols and embedded in Epon 812 (TAAB 
Laboratories). Ultrathin sections were cut on an Ultracut UCT ultramicro-
tome (Leica) and stained with lead citrate (sections of RR-treated cells 
  remained unstained).
For immunolabeling, HIV-infected MDMs or uninfected control cells 
were ﬁ  xed by adding an equal volume of prewarmed double-strength 
ﬁ  xative (8% PFA in 0.1 M NaPi buffer, pH7.4) directly into the culture 
medium. After 10 min, the medium was replaced with 4% PFA. Cells were 
rinsed in PBS containing 20 mM glycine, embedded in 12% gelatine, in-
ﬁ  ltrated with 2.3 M sucrose, and frozen in liquid nitrogen as previously 
described (Raposo et al., 1997). Semithin (0.5 μm) or ultrathin (50 nm) 
cryosections were cut on an Ultracut UCT microtome equipped with an EM 
FCS cryochamber.
Immunoﬂ  uorescence staining. Semithin cryosections on glass slides 
were quenched in 50 mM glycine/50 mM NH4Cl, labeled with antibodies 
diluted in PBS 1% BSA, and mounted in Mowiol. Sections were examined at 
RT with a microscope (Axioskop; Carl Zeiss MicroImaging, Inc.) ﬁ  tted with 
Plan Neoﬂ  uar oil immersion objectives (63×/1.25 NA or 100×/1.30 NA). 
Images were recorded with a charge-coupled device camera (Orca 
C4742-95; Hamamatsu) controlled by Openlab 3.1.7 software (Improvision), 
false colored, converted to TIFF ﬁ  les, adjusted for brightness and contrast 
and assembled into montages with Photoshop 8.
EM immunolabeling. Ultrathin cryosections on formvar-coated grids 
were quenched as above and labeled with primary antibodies and PAG 
(5, 10, or 15 nm). Sections stained with mouse mAb were incubated with a 
rabbit anti–mouse bridging antibody before labeling with PAG. For double 
labeling, cells were ﬁ  rst stained with mouse mAbs, the rabbit anti–mouse 
bridging antibody, and PAG, and ﬁ  xed in 1% glutaraldehyde for 10 min 
before requenching and staining with a rabbit antiserum against HIV p17. 
Sections were examined with an EM420 (Philips) or a CM10 transmission 
EM (FEI), and images were recorded onto electron image ﬁ  lm (SO-163; 
  Kodak). Negatives were digitized with a FlexTight Precision II rotating drum 
charge-coupled device scanner (Imacon), and TIFF images were acquired 
with the ColorFlex 1.9.5 FlexTight Interface Software. Alternatively, speci-
mens were examined with a Tecnai G2 Spirit transmission EM (FEI) and digi-
tal images were recorded with a Morada 11 MegaPixel TEM camera (Soft 
Imaging System) and the AnalySIS software package. Images were   adjusted 
for brightness and contrast and ﬁ  gures were assembled with   Photoshop 8.
Online supplemental material
Fig. S1 shows immunoﬂ  uorescence staining for HIV and CD63, CD81, or 
CD9 on semithin cryosections. Fig. S2 shows control experiments for the 
feeding of anti-CD81 or -CD9. Fig. S3 shows how closely apposed mem-
brane sheets connect different VCCs, and Fig. S4 shows serial sections of 
VCCs in HIV-infected MDMs. Fig. S5 shows feeding of anti-CD63 on un-
infected MDMs. The online version of this article is available at http://www
.jcb.org/cgi/content/full/jcb.200609050/DC1.
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